Hey, can you explain me the three layers of the filtration barrier where we have the basement membrane and we have the, what do you say, epithelial cells or podocytes? And then below that, we'll have some other cells, I don't remember. So all of this make the filtration barrier and depth podocytes are effaced. Then it is membranous nephropathy, and what is focal segmental glomerulosclerosis, what is membranous nephropathy, what is membranoproliferative glomerulonephritis, and explain me that little concept. Three USMLE-based ultra-high yield, ultra-short notes, small diagrams of filtration so I can remember.

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
I now have everything needed to write a thorough, USMLE-focused answer. Let me compose it.

The Glomerular Filtration Barrier + Glomerulonephropathies - USMLE Ultra-High Yield Notes


PART 1 - THE THREE-LAYER FILTRATION BARRIER

The glomerular filtration barrier sits between the capillary lumen and Bowman's space. Think of it as three concentric filters stacked from inside out:
CAPILLARY LUMEN
        │
┌───────▼──────────────────────────────┐
│  LAYER 1 - FENESTRATED ENDOTHELIUM   │
│  • Large pores (70–100 nm)            │
│  • Covered by negatively charged      │
│    glycocalyx (heparan sulfate)       │
│  → Filters by SIZE (large cells out)  │
│  → Does NOT stop albumin alone        │
└───────────────────────────────────────┘
        │
┌───────▼──────────────────────────────┐
│  LAYER 2 - GBM (Glomerular Basement  │
│  Membrane) ~250–400 nm thick          │
│  • Type IV collagen + laminin 521      │
│  • Heparan sulfate proteoglycans       │
│    (strongly NEGATIVE charge)         │
│  → Filters by SIZE + CHARGE           │
│  → Main barrier to albumin (negative) │
└───────────────────────────────────────┘
        │
┌───────▼──────────────────────────────┐
│  LAYER 3 - PODOCYTE FOOT PROCESSES   │
│  (Visceral Epithelial Cells)          │
│  • Foot processes interdigitate       │
│  • Connected by SLIT DIAPHRAGM        │
│    (nephrin, podocin, CD2AP)          │
│  → Final barrier - most specific      │
│  → Effacement = loss of foot procs    │
└───────────────────────────────────────┘
        │
  BOWMAN'S SPACE (filtrate)
Here is the actual electron micrograph and schematic from Brenner & Rector showing all three layers:
Filtration barrier EM: podocyte foot processes (SD = slit diaphragm), GBM, and fenestrated endothelium clearly labeled
Podocyte slit diaphragm molecular architecture - nephrin, podocin, alpha-actinin-4, TRPC6 and their connections to GBM and endothelium

The "fourth cell" you were thinking of - MESANGIAL CELLS

  • Sit between the capillary loops (contiguous with the subendothelial space)
  • NOT part of the filtration barrier itself
  • Role: structural support, phagocytosis of trapped immune complexes, contractile regulation of GFR
  • They are the ones that proliferate in IgA nephropathy and MPGN

THE EFFACEMENT CONCEPT - KEY TEST DISCRIMINATOR

FindingDisease
Diffuse foot process effacement, NO depositsMinimal Change Disease (MCD)
Diffuse foot process effacement + segmental sclerosisFSGS
Subepithelial ("spike and dome") depositsMembranous Nephropathy
Subendothelial deposits + "tram-track" GBMMPGN
Mesangial IgA depositsIgA Nephropathy

PART 2 - THE THREE DISEASES (USMLE NOTES)


NOTE 1 - FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)

Keyword: PODOCYTE LOSS beyond the capacity to compensate
FSGS
│
├─ "Focal" = only SOME glomeruli affected (<50%)
├─ "Segmental" = only PART of a glomerulus is sclerosed
│
├─ PATHOGENESIS
│   ├─ Primary: circulating permeability factor (suPAR)
│   │   injures podocytes → foot process effacement
│   │   → podocyte dropout → bare GBM → hyalinosis
│   ├─ Secondary: HIV (HIVAN - collapsing variant)
│   │   heroin, sickle cell, obesity, APOL1 mutations
│   │   (Black patients - high-risk G1/G2 alleles)
│   └─ Inherited: nephrin, podocin, alpha-actinin-4 mutations
│
├─ PRESENTATION  → NEPHROTIC SYNDROME
│   ├─ Massive proteinuria (non-selective)
│   ├─ Edema, hypoalbuminemia, hyperlipidemia
│   └─ Hematuria + HTN more common than MCD
│
├─ MICRO (EM)
│   ├─ Diffuse foot process effacement
│   ├─ NO immune deposits (vs membranous)
│   └─ Segmental collapse/sclerosis of capillary tuft
│
├─ IMMUNOFLUORESCENCE: Negative (no immune complexes)
│
└─ PROGNOSIS
    ├─ Poor response to steroids (vs MCD which responds well)
    ├─ 50% → ESKD within 10 years
    └─ Recurs in 25-50% of transplants (circulating factor!)
USMLE ONE-LINER: Black patient or HIV patient with nephrotic syndrome, non-selective proteinuria, steroid-resistant = FSGS. Look for APOL1 risk alleles.

NOTE 2 - MEMBRANOUS NEPHROPATHY (MN)

Keyword: SUBEPITHELIAL IMMUNE DEPOSITS ("spike and dome")
MEMBRANOUS NEPHROPATHY
│
├─ PRIMARY (75%): Anti-PLA2R antibodies (IgG4)
│   → Antibody binds PLA2R on podocyte surface
│   → Complement activation (MAC = C5b-9)
│   → Immune complexes shed → lodge SUBEPITHELIALLY
│   → GBM grows "spikes" around deposits
│
├─ SECONDARY (25%):
│   ├─ Drugs: NSAIDs, penicillamine, gold, captopril
│   ├─ Malignancy: lung/colon cancer, melanoma
│   ├─ Infections: HBV, HCV, syphilis, malaria
│   └─ SLE (Class V lupus nephritis)
│
├─ PRESENTATION → NEPHROTIC SYNDROME
│   ├─ Most common cause of nephrotic syndrome in ADULTS
│   ├─ Massive proteinuria (selective early, then non-selective)
│   └─ NO hematuria early (non-inflammatory)
│
├─ MICRO
│   ├─ LM: Diffuse thickening of capillary wall
│   │   Silver stain → "spike and dome" (GBM spikes
│   │   projecting up between subepithelial deposits)
│   ├─ EM: Subepithelial electron-dense deposits
│   │   (Stages I→IV: deposits grow, GBM encircles them)
│   └─ IF: Granular IgG + C3 along GBM
│
└─ PROGNOSIS: "Rule of thirds"
    ├─ 1/3 spontaneous remission
    ├─ 1/3 persistent proteinuria, stable function
    └─ 1/3 progressive → renal failure
USMLE ONE-LINER: Adult nephrotic syndrome with spike-and-dome on silver stain + granular IgG on IF + subepithelial deposits on EM = Membranous Nephropathy. Rule out malignancy!

NOTE 3 - MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN)

Keyword: TRAM-TRACK GBM + LOBULAR GLOMERULI + BOTH NEPHROTIC AND NEPHRITIC
MPGN
│
├─ It's a PATTERN not a single disease
│
├─ TYPE I (Immune Complex-mediated, IC-MPGN)
│   ├─ Cause: HCV (most common), HBV, SLE,
│   │         endocarditis, cryoglobulinemia
│   ├─ Deposits: SUBENDOTHELIAL + mesangial
│   ├─ Complement: C3 low, C4 low (classical pathway)
│   └─ IF: IgG + C3 + C1q + C4 (full house early)
│
├─ C3 GLOMERULOPATHY (old "Type II" / Dense Deposit Disease)
│   ├─ Cause: C3 nephritic factor (C3NeF) autoantibody
│   │         → stabilizes C3 convertase → uncontrolled
│   │         alternative complement activation
│   ├─ Deposits: Intramembranous dense ribbonlike material
│   ├─ Complement: C3 very low, C4 NORMAL
│   └─ IF: C3 only (no IgG, no C1q, no C4)
│
├─ PRESENTATION
│   ├─ MIXED nephrotic + nephritic picture
│   ├─ Hematuria + proteinuria + hypertension + edema
│   ├─ Low serum C3 in both types
│   └─ Young adults, adolescents
│
├─ MICRO
│   ├─ LM: Large, hypercellular lobular glomeruli
│   │       "Tram-track" / double-contour GBM
│   │       (silver or PAS stain)
│   │       Mesangial interposition between split GBMs
│   └─ EM: Subendothelial deposits (Type I)
│           or dense intramembranous ribbons (Type II/DDD)
│
└─ PROGNOSIS: Poor - 50% → chronic renal failure in 10 years
USMLE ONE-LINER: Patient with HCV + mixed nephrotic-nephritic syndrome + LOW C3 + tram-track on silver stain = MPGN Type I. If C4 is NORMAL with very low C3, think C3 glomerulopathy/DDD.

MASTER SUMMARY TABLE

MCDFSGSMNMPGN
SyndromeNephroticNephroticNephroticBoth
AgeKidsAdults/KidsAdultsAdolescents
LMNormalFocal-segmental sclerosisThick walls, spikesLobular, tram-track
EMDiffuse foot process effacement, NO depositsSame + segmental sclerosis, NO depositsSubepithelial depositsSubendothelial deposits
IFNegativeNegativeGranular IgG+C3 along GBMIgG+C3 (Type I); C3 only (Type II)
ComplementNormalNormalNormalLow C3 (+/- C4)
Key antigen/causeUnknown (permeability factor)APOL1, HIV, obesity, podocin/nephrin mutationsAnti-PLA2R (75%)HCV, C3NeF
Steroid responseExcellentPoorPartialNone

DEPOSIT LOCATION - THE ULTIMATE CHEAT SHEET

GLOMERULAR CAPILLARY CROSS-SECTION:

   BOWMAN'S SPACE
         │
   [PODOCYTE FOOT PROCESS]
         │
   ← Subepithelial ← (MN = "spike and dome")
         │
   [  G   B   M  ]
         │
   ← Intramembranous ← (DDD/C3GN = dense ribbons)
         │
   ← Subendothelial ← (MPGN Type I, SLE)
         │
   [ENDOTHELIUM - fenestrated]
         │
   CAPILLARY LUMEN
         │
   ← Mesangial ← (IgA nephropathy, mesangial lupus)

Sources: Robbins, Cotran & Kumar Pathologic Basis of Disease (Robbins Pathology); Brenner and Rector's The Kidney; National Kidney Foundation Primer on Kidney Diseases, 8e

Create a quick-reference PDF summarizing filtration barrier layers and three glomerulonephropathies

Reading File
Running Command
Writing File
Running Command
Editing File
Running Command
Editing File
Running Command
Running Command
Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.
This is a shared conversation. Sign in to Orris to start your own chat.